Tests a gamma light lamp's effect on brain waves in healthy older adults
Tests a gamma light lamp in cognitively healthy adults aged 55 and older.
Plain-language title generated from the registry record
Registry title: Effects of Endogenous Gamma Light Stimulation on Brain Oscillations in Cognitively-normal Older Adults
Key facts
- Where
- Taoyuan, TaiwanSee the site
Where in Taiwan
- Chang Gung UniversityTaoyuan, TaiwanTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Chang Gung Memorial Hospital
- Trial code
- NCT06715995
- Record updated
- 4 December 2024
- Original description
This study aims to evaluate the effects of endogenous gamma non-flickering light stimulation on resting-state EEG rhythms and cognitive function in cognitively healthy older adults. Specifically, it will assess the immediate and long-term effects of this stimulation on brainwave activity and cognitive performance. The study will explore the potential of gamma light stimulation as a non-pharmacological intervention for cognitive decline in aging populations.Read full original descriptionShow less
Effects of Endogenous Gamma Light Stimulation on Brain Oscillations in Cognitively-normal Older Adults: a Randomized, Placebo-controlled, Double-blind Study
This study aims to evaluate the effects of endogenous gamma non-flickering light stimulation on resting-state EEG rhythms and cognitive function in cognitively healthy older adults. Specifically, it will assess the immediate and long-term effects of this stimulation on brainwave activity and cognitive performance. The study will explore the potential of gamma light stimulation as a non-pharmacological intervention for cognitive decline in aging populations.
Inclusion: 1. Age over 55 years old; 2. The Cognitive Abilities Screening Instrument (CASI) score is within normal ranges adjusted for age and education; 3. Participants have no history of severe neurological or psychiatric disorders (such as stroke, epilepsy, depression, migraine, etc.) that could affect cognitive function; 4. Participants have not used drugs that may affect cognitive function (e.g., benzodiazepines, anticholinergic medications, etc.); 5. Participants with normal or corrected vision (e.g., glasses or contact lenses) to normal levels; 6. Voluntary to sign the Informed Consent Form.
Exclusion: 2. Participants with a history of disease that could affect cognitive function (e.g., cancer, autoimmune diseases, etc.); 1. Participants enrolled in any cognitive enhancement study within the past two months; 3. Pregnant, or planning to become pregnant.